Profile: IPCA Laboratories Ltd (IPCA.BO)

IPCA.BO on Bombay Stock Exchange

746.50INR
28 Aug 2014
Price Change (% chg)

Rs-8.90 (-1.18%)
Prev Close
Rs755.40
Open
Rs760.00
Day's High
Rs760.00
Day's Low
Rs740.00
Volume
14,748
Avg. Vol
44,023
52-wk High
Rs906.90
52-wk Low
Rs615.00

Search Stocks
IPCA Laboratories Limited is a pharmaceutical company. The Company is a manufacturer of active pharmaceutical ingredients (APIs)-Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Furosemide (diuretic), Hydroxychloroquine Sulphate (NSAID), Metoprolol Succinate (anti-hypertensive), Metoprolol Tartrate (anti-hypertensive) and Pyrantel Salts (anthelmintic). Its formulations basket includes generics for the developed markets and branded formulations for emerging markets. The Company manufactures over 350 formulations in virtually every dosage form: oral solids and liquids, dry powders for suspension, and injectables (liquid and dry). The Company’s subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd., Ipca Pharma Nigeria Ltd., National Druggist (PTY) Ltd and Ipca Pharma (Australia) Pty Ltd.

Company Address

IPCA Laboratories Ltd

142 AB, Kandivli Industrial Esta
Kandivli (West)
MUMBAI     400067
P: +9122.66474747
F: +9122.28686954

Company Web Links

Search Stocks